These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3136649

  • 21. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ.
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and metabolism of encainide.
    Jaillon P.
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():561-5. PubMed ID: 2125833
    [Abstract] [Full Text] [Related]

  • 23. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
    Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM.
    Circulation; 1988 Feb; 77(2):380-91. PubMed ID: 3123092
    [Abstract] [Full Text] [Related]

  • 24. Flecainide and CAST.
    Lancet; 1989 Aug 26; 2(8661):481-2. PubMed ID: 2570188
    [No Abstract] [Full Text] [Related]

  • 25. Encainide and flecainide: are they interchangeable?
    Saini V, Podrid PJ, Slater W, Lown B.
    Am Heart J; 1989 Jun 26; 117(6):1253-8. PubMed ID: 2499169
    [Abstract] [Full Text] [Related]

  • 26. Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
    Mäkynen PJ, Koskinen PJ, Saaristo TE, Liisanantti RK.
    Am J Cardiol; 1988 Dec 20; 62(19):55L-59L. PubMed ID: 3144169
    [Abstract] [Full Text] [Related]

  • 27. Antiarrhythmic therapy--conventional wisdom challenged.
    Turakhia DP.
    J Assoc Physicians India; 1990 Aug 20; 38(8):605. PubMed ID: 2123185
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical pharmacokinetics of encainide.
    Roden DM, Woosley RL.
    Clin Pharmacokinet; 1988 Mar 20; 14(3):141-7. PubMed ID: 3131058
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN, Morganroth J.
    J Am Coll Cardiol; 1987 Feb 20; 9(2):459-63. PubMed ID: 3100601
    [No Abstract] [Full Text] [Related]

  • 35. Encainide: a new and potent antiarrhythmic agent.
    Harrison DC, Winkle R, Sami M, Mason J.
    Am Heart J; 1980 Dec 20; 100(6 Pt 2):1046-54. PubMed ID: 6778194
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J, Klein H, Shanks RG, Bender F.
    Z Kardiol; 1985 Apr 20; 74(4):220-7. PubMed ID: 2408392
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.